Inactive Instrument

News Inspyr Therapeutics, Inc. Other OTC

Equities

NSPX

US45782A4031

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Rebus Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	21/08/23	CI
Rebus Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
REBUS HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	31/03/23	AQ
Rebus Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	31/03/23	CI
Rebus Holdings, Inc. Auditor Raises 'Going Concern' Doubt	30/03/23	CI
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	21/11/22	AQ
Rebus Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	21/11/22	CI
REBUS HOLDINGS, INC. : Changes in Registrant's Certifying Accountant (form 8-K)	16/11/22	AQ
REBUS HOLDINGS, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	13/10/22	AQ
Rebus : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)	12/08/22	PU
Rebus Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/08/22	CI
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	12/08/22	AQ
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	13/05/22	AQ
Rebus Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/05/22	CI
Rebus Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22	CI
REBUS HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	31/03/22	AQ
Rebus Holdings, Inc. Auditor Raises 'Going Concern' Doubt	30/03/22	CI
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	12/11/21	AQ
Rebus Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/11/21	CI
Inspyr Therapeutics : Material Event - Form 8-K/A	12/10/21	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Inspyr Therapeutics, Inc. Other OTC

Equities

NSPX

US45782A4031

Summary

Filters